| 摘要 |
<p>The present invention involves a novel cloned human brain lysophospholipase, its kinetic parameters and its use in the treatment of disease states having elevated concentrations of lysophospholipids, such as atherosclerosis, hyperlipidemia, lethal dysrhythmias in myocardial ischemia and segmental demyelination of peripheral nerves.</p> |
